drugset
drugset / Trial / NCT06851598

Safety and Efficacy of Botulinum Toxin-A Injection Into Ischiocavernosus Muscle for Premature Ejaculation

NCT06851598 ↗

Phase 2/3 Active not recruiting 45 enrolled Abdallah Mohamed Abdallah Mohamed Elgendy
RandomizedParallel-groupOpen-labelTreatment

Summary

The aim of this work is to assess the efficacy and safety of Botulinum toxin - A injection into ischiocavernosus muscle in treatment of primary premature ejaculation.

Timeline

Start
2024-07-01
Primary completion
2025-02-01
Completion
2025-03-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Botulinum toxin type A Protein / enzyme biologic 25 iu Intramuscular
Subject Botulinum toxin type A Protein / enzyme biologic 50 iu Intramuscular
Subject Botulinum toxin type A Protein / enzyme biologic 75 iu Intramuscular

Indications

premature ejaculation